These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 9069162)
21. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Delmas PD; Recker RR; Chesnut CH; Skag A; Stakkestad JA; Emkey R; Gilbride J; Schimmer RC; Christiansen C Osteoporos Int; 2004 Oct; 15(10):792-8. PubMed ID: 15071723 [TBL] [Abstract][Full Text] [Related]
22. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. Bauer DC; Garnero P; Hochberg MC; Santora A; Delmas P; Ewing SK; Black DM; J Bone Miner Res; 2006 Feb; 21(2):292-9. PubMed ID: 16418785 [TBL] [Abstract][Full Text] [Related]
23. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis. Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967 [TBL] [Abstract][Full Text] [Related]
24. Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass. Park SM; Joung JY; Cho YY; Sohn SY; Hur KY; Kim JH; Kim SW; Chung JH; Lee MK; Min YK Eur J Clin Nutr; 2015 Mar; 69(3):361-6. PubMed ID: 25649239 [TBL] [Abstract][Full Text] [Related]
25. Site-specific variation in the classification of osteoporosis, and the diagnostic reclassification using the lowest individual lumbar vertebra T-score compared with the L1-L4 mean, in early postmenopausal women. Sahota O; Pearson D; Cawte SW; San P; Hosking DJ Osteoporos Int; 2000; 11(10):852-7. PubMed ID: 11199189 [TBL] [Abstract][Full Text] [Related]
26. [Investigation on bone health conditions in 1637 aged women]. Li HL; Zhu HM; Cheng Q; Du YP; Hong W; Zhu XY; Zhang XM; Xue SH; Gan JM Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):492-5. PubMed ID: 22041439 [TBL] [Abstract][Full Text] [Related]
27. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ; J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495 [TBL] [Abstract][Full Text] [Related]
28. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854 [TBL] [Abstract][Full Text] [Related]
29. Relationship of bone turnover to bone density and fractures. Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008 [TBL] [Abstract][Full Text] [Related]
30. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758 [TBL] [Abstract][Full Text] [Related]
31. Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011. Hwang IR; Choi YK; Lee WK; Kim JG; Lee IK; Kim SW; Park KG Osteoporos Int; 2016 Jan; 27(1):257-65. PubMed ID: 26373982 [TBL] [Abstract][Full Text] [Related]
32. Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study. Qu XL; Zheng B; Chen TY; Cao ZR; Qu B; Jiang T Orthop Surg; 2020 Feb; 12(1):116-123. PubMed ID: 31880071 [TBL] [Abstract][Full Text] [Related]
33. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. Gertz BJ; Shao P; Hanson DA; Quan H; Harris ST; Genant HK; Chesnut CH; Eyre DR J Bone Miner Res; 1994 Feb; 9(2):135-42. PubMed ID: 8140926 [TBL] [Abstract][Full Text] [Related]
34. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial. Reginster JY; Meurmans L; Zegels B; Rovati LC; Minne HW; Giacovelli G; Taquet AN; Setnikar I; Collette J; Gosset C Ann Intern Med; 1998 Jul; 129(1):1-8. PubMed ID: 9652994 [TBL] [Abstract][Full Text] [Related]
35. Bone turnover and its relationship with bone mineral density in pre- and postmenopausal women with or without fractures. Minisola S; Pacitti MT; Ombricolo E; Costa G; Scarda A; Palombo E; Rosso R Maturitas; 1998 Jun; 29(3):265-70. PubMed ID: 9699199 [TBL] [Abstract][Full Text] [Related]
36. Low bone mineral density, but not epidural steroid injection, is associated with fracture in postmenopausal women with low back pain. Yi Y; Hwang B; Son H; Cheong I Pain Physician; 2012; 15(6):441-9. PubMed ID: 23159959 [TBL] [Abstract][Full Text] [Related]
37. The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate. Middleton ET; Steel SA; Aye M; Doherty SM J Bone Miner Res; 2010 Mar; 25(3):455-62. PubMed ID: 20201000 [TBL] [Abstract][Full Text] [Related]
38. [Influence on adjacent lumbar bone density after strengthening of T12, L1 segment vertebral osteoporotic compression fracture by percutaneous vertebroplasty and percutaneous kyphoplasty]. Zhang C; Zhu K; Zhou J; Zhou X; Niu G; Wu M; Shao C Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):819-23. PubMed ID: 24063170 [TBL] [Abstract][Full Text] [Related]
39. Increases in hip and spine bone mineral density are predictive for vertebral antifracture efficacy with ibandronate. Miller PD; Delmas PD; Huss H; Patel KM; Schimmer RC; Adami S; Recker RR Calcif Tissue Int; 2010 Oct; 87(4):305-13. PubMed ID: 20737140 [TBL] [Abstract][Full Text] [Related]
40. Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis. Iwamoto J; Takeda T; Ichimura S; Matsu K; Uzawa M J Orthop Sci; 2003; 8(4):532-7. PubMed ID: 12898306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]